The FDA may limit annual COVID-19 boosters to high-risk groups unless clinical trials prove benefits for healthy adults under ...

The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.

The U.S. Food and Drug Administration’s decision to limit COVID vaccines to people 65 and older and others with underlying ...

The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to ...

Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.

The mRNA vaccines were developed using novel technology that was approved for the first time for public use during the COVID-19 pandemic.

On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine. The ...

The US FDA may limit Covid-19 boosters to high-risk groups only, citing lack of efficacy in healthy individuals. Meanwhile, ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...

The FDA is moving to restrict COVID vaccination to adults 65 and older and other particularly vulnerable people. Learn what’s ...

The U.S. Food and Drug Administration will now require COVID-19 vaccines from Pfizer/BioNTech and Moderna to use expanded ...

Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to ...